info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Secondary parkinsonism

PD2ND

secondary Parkinson disease: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 G21
Hospital discharge: ICD-9 3321
Cause of death: ICD-10 G21
Cause of death: ICD-9 3321

2 out of 7 registries used, show all original rules.

809

diagram downward connector

Check minimum number of events None

809

diagram downward connector

Include endpoints None

809

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

784

diagram downward connector
PD2ND

Control definitions

Control exclude G6_PARKINSON

Extra metadata

First used in FinnGen datafreeze DF2
Parent code in ICD-10 G20-G26
Name in latin Parkinsonismus secundarius

Summary Statistics

Key figures

All Female Male
Number of individuals 784 323 461
Unadjusted prevalence (%) 0.19 0.14 0.25
Mean age at first event (years) 63.03 63.04 63.02

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: PD2ND – Secondary parkinsonism
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Secondary parkinsonism

Endpoint not on priority list, no data to show.